Labs should demo real-world wins like new Alzheimer's drugs, not "book travel", says researcher
Afinetheorem · x · 2026-11-18
Responding to Miles Brundage's critique of OpenAI's ad messaging, the author advises lab comms teams: every new model release should demo concrete real-world impact — "GSK has a new Alzheimer's drug we helped develop" or "AI redid Seattle's traffic lights and cut commutes by X" — not "book travel," math proofs, or dystopia framing.
More from AGI Musings
- Nadella: every Microsoft IC will manage agents with a token budget — petergyang · 2026-11-18
- Stanford HAI dashboards show AI-exposed jobs down 4%+ this year — StanfordHAI · 2026-11-18
- Lab throughput too low for AI drug discovery, argues debater as opposite view gains traction — niloofar_mire · 2026-11-18
- Calling every AI breakthrough 'hype' will make for a confusing decade, argues X user — VraserX · 2026-11-18
- giffmana: he's starting to worry about AI cyber offense and deepfakes too — giffmana · 2026-11-18
- Contour (YC F26) launches AI-native environmental permitting, buying permit firms outright — ycombinator · 2026-11-18